Doctor profile · Federal record
Dr. Adaeze Egesi, M.D.
Dermatology Physician (CMS: Dermatology) · Humble, TX
- NPI 1982929006
- Accepts Medicare
- MIPS 66.8 / 100 · 2023
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
18980 N Memorial Dr Ste 200
Humble, TX 773384498
(281) 707-6400
fax (281) 584-6432
Credentials & registration
- NPI registered
- March 2010 — 16 yrs on file
- Profile last updated
- August 12, 2022
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #P9336
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1982929006. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,906
Distinct HCPCS
10
Medicare allowed
$133,247
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 456 | 66 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 389 | 198 | $129 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 239 | 44 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 162 | 123 | $91 | |
11900 |
Injection into skin growth, 1-7 growths | 147 | 55 | $56 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 117 | 117 | $168 | |
17110 |
Destruction of skin growth, 1-14 growths | 115 | 89 | $114 | |
17000 |
Destruction of precancer skin growth, 1 growth | 79 | 60 | $53 | |
11102 |
Biopsy of related skin growth, first growth | 66 | 64 | $90 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 48 | 37 | $173 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 175. This provider delivers 11× the peer median.Open Payments
Industry payments received
All-time total
$9,953
Transactions
152
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 8 | $3,692.35 | |
| Dermavant Sciences, Inc. | 13 | $3,428.56 | |
| Janssen Biotech, Inc. | 19 | $506.72 | |
| ABBVIE INC. | 22 | $466.76 | |
| Arcutis Biotherapeutics, Inc. | 17 | $298.40 | |
| Galderma Laboratories, L.P. | 14 | $271.42 | |
| Regeneron Healthcare Solutions, Inc. | 4 | $229.00 | |
| Novartis Pharmaceuticals Corporation | 11 | $200.51 | |
| Amgen Inc. | 8 | $196.27 | |
| PFIZER INC. | 15 | $154.08 | |
| E.R. Squibb & Sons, L.L.C. | 9 | $153.68 | |
| UCB, Inc. | 3 | $95.93 | |
| GENZYME CORPORATION | 3 | $69.37 | |
| LEO Pharma Inc. | 4 | $58.96 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55.48 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,308
Patients
740
Total drug cost
$176,500
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Minoxidil | Generic | 172 | 76 | $4,426 |
| Mupirocin | Generic | 129 | 95 | $1,135 |
| Clobetasol Propionate | Generic | 126 | 60 | $7,709 |
| Doxycycline Hyclate | Generic | 102 | 72 | $4,084 |
| Finasteride | Generic | 99 | 57 | $1,408 |
| Triamcinolone Acetonide | Generic | 97 | 73 | $749 |
| Halobetasol Propionate | Generic | 95 | 70 | $10,037 |
| Ketoconazole | Generic | 92 | 51 | $1,406 |
| Dutasteride | Generic | 78 | 33 | $3,079 |
| Levocetirizine Dihydrochloride | Generic | 75 | 38 | $952 |
Frequently asked questions
What is Dr. Adaeze Egesi's medical specialty?
Dr. Adaeze Egesi practices Dermatology Physician in Humble, TX.
Where does Dr. Adaeze Egesi practice?
Dr. Adaeze Egesi practices at 18980 N Memorial Dr Ste 200, Humble, TX 773384498. Office phone: 2817076400.
What is Dr. Adaeze Egesi's NPI?
Dr. Adaeze Egesi's National Provider Identifier (NPI) is 1982929006, issued by NPPES.
Does Dr. Adaeze Egesi accept Medicare assignment?
Yes. Dr. Adaeze Egesi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adaeze Egesi commonly perform?
Top Medicare-reported procedures in 2023: Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS J3301); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.